Skip to content

SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision

Comparison of Airway Control Effectiveness of the SafeLM Video Laryngeal Mask and the LMA Classic in Patients Undergoing General Anesthesia for Fibroadenoma Excision

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07835750
Enrollment
132
Registered
2026-09-23
Start date
2026-10-01
Completion date
2027-07-01
Last updated
2026-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management

Keywords

Laryngeal Mask Airway, Video Laryngeal Mask, SafeLM, LMA Classic, Oropharyngeal Leak Pressure, Supraglottic Airway Device, General Anesthesia, Fibroadenoma Excision

Brief summary

This randomized controlled trial compares the airway management performance of the SafeLM video laryngeal mask with the LMA Classic in adult patients undergoing elective fibroadenoma excision under general anesthesia. Participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. The primary outcome is oropharyngeal leak pressure. Secondary outcomes include insertion performance, ventilation parameters, hemodynamic responses, and airway-related adverse events.

Detailed description

The SafeLM is a video-assisted laryngeal mask that allows visualization during placement, whereas the LMA Classic is a conventional supraglottic airway device. This study is designed to compare the clinical performance of these two devices under standardized conditions. Adult patients scheduled for elective fibroadenoma excision under general anesthesia will be screened for eligibility. Only patients for whom both devices are considered clinically appropriate will be enrolled, thereby avoiding randomization when patient characteristics indicate a preference for a particular airway management technique. Eligible participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. After standardized induction of general anesthesia, the assigned laryngeal mask will be inserted according to the study protocol. The primary outcome is oropharyngeal leak pressure after successful placement. Device insertion characteristics, ventilation parameters, hemodynamic responses, and airway-related adverse events will also be evaluated.

Interventions

DEVICESafeLM Video Laryngeal Mask

The SafeLM is a video-assisted supraglottic airway device that allows visualization of the laryngeal structures during insertion and positioning. It will be used for airway management during general anesthesia according to the standardized study protocol.

The LMA Classic is a conventional supraglottic airway device without video guidance. It will be used for airway management during general anesthesia according to the standardized study protocol.

Sponsors

Hanoi Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Participants will be unaware of the assigned laryngeal mask device. The anesthesiologist performing device insertion and intraoperative outcome assessment cannot be masked because of the visible differences between the two devices.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female patients aged 18 years or older. * Scheduled for elective excision of benign breast fibroadenoma under general anesthesia. * Planned airway management with a laryngeal mask airway. * American Society of Anesthesiologists (ASA) physical status I-II. * Both the SafeLM and LMA Classic are considered clinically appropriate for airway management. * Provision of written informed consent.

Exclusion criteria

* Increased risk of pulmonary aspiration, including inadequate preoperative fasting, full stomach, or gastrointestinal obstruction. * Known or suspected difficult airway or other airway characteristics for which random allocation between the two study devices is considered clinically inappropriate. * Upper airway pathology or anatomical abnormality that may interfere with laryngeal mask placement. * Clinical or surgical indication requiring tracheal intubation rather than a laryngeal mask airway. * Contraindication or known allergy to medications used in the standardized anesthesia protocol. * Inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal Leak Pressure (OLP)Immediately after successful laryngeal mask placement, before the start of surgeryOropharyngeal leak pressure will be measured after successful placement of the assigned laryngeal mask and establishment of effective ventilation. OLP will be recorded in cmH2O as the airway pressure at which an audible oropharyngeal leak is detected during a standardized leak test.

Secondary

MeasureTime frameDescription
First-attempt insertion successDuring initial laryngeal mask insertionProportion of participants in whom effective ventilation is achieved after the first insertion attempt of the assigned laryngeal mask.
Overall insertion successDuring laryngeal mask insertion, up to 3 attemptsProportion of participants in whom effective ventilation is achieved with the assigned laryngeal mask within the maximum number of insertion attempts permitted by the study protocol.
Laryngeal mask insertion timeDuring laryngeal mask insertionTime in seconds from introduction of the assigned laryngeal mask into the mouth until establishment of effective ventilation.
Number of insertion attemptsDuring laryngeal mask insertionNumber of attempts required to achieve successful placement and effective ventilation with the assigned laryngeal mask.
Need for additional airway maneuversDuring laryngeal mask insertionProportion of participants requiring additional maneuvers to achieve satisfactory placement and ventilation.
Peak inspiratory pressureAt 5 and 30 minutes after successful laryngeal mask placementPeak inspiratory airway pressure measured in cmH2O during mechanical ventilation.
End-tidal carbon dioxideAt 5 and 30 minutes after successful laryngeal mask placementEnd-tidal carbon dioxide (EtCO2) measured during mechanical ventilation.
Heart RateAt baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placementHeart rate will be recorded in beats per minute (bpm).
Blood staining on the laryngeal maskImmediately after device removalPresence of visible blood staining on the laryngeal mask after removal.
Postoperative sore throatAt 1 and 24 hours after surgeryPresence of patient-reported sore throat following general anesthesia.
Postoperative hoarsenessAt 1 and 24 hours after surgeryPresence of patient-reported hoarseness following general anesthesia.
Airway-related adverse eventsFrom laryngeal mask insertion through postoperative observation, assessed up to 24 hours after surgeryOccurrence of airway-related adverse events, including laryngospasm and clinically evident regurgitation.
Arterial PressureAt baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placementArterial pressure will be recorded in mmHg.

Contacts

CONTACTHung T. Tran, MD
thanhhungvt@gmail.com+84367378519

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 8, 2026